Dr. Reddy's gets Canada approval for generic semaglutide, 1st G7
NewsBytes | April 29, 2026 10:40 PM CST
Dr. Reddy's $100 million potential in Canada
With Canada's semaglutide market topping $1.5 billion, Dr. Reddy's could earn up to $100 million in fiscal 2027 before major rivals show up.
Analysts say they have about six to nine months of head start.
READ NEXT
-
'David Beckham of snooker' died of cancer aged 27 after just one symptom
-
Question Time's Fiona Bruce fumes as Reform's Zia Yusuf refuses to answer question 5 times
-
Fiona Bruce halts Question Time as she makes important announcement
-
Gary Lineker makes cheeky BBC World Cup dig ahead of £14m Netflix show
-
New Lidl store in UK seaside town delayed for bizarre reason
